Sanofi News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

14.09.20	Regeneron And Sanofi: Dupixent Granted FDA Breakthrough Therapy Designation For EoE (RTTNews)
14.09.20	FDA grants Dupixent® (dupilumab) Breakthrough Therapy designation for eosinophilic esophagitis (GlobeNewswire)
10.09.20	New England Journal of Medicine publishes positive final results from Phase 1/2a study of BIVV001 in people with severe hemophilia A (GlobeNewswire)
08.09.20	Regeneron/Sanofi Reveal Promising Long-term Data Of Dupixent In Moderate-to-severe Asthma (RTTNews)
08.09.20	Dupixent® (dupilumab) long-term data show sustained improvement in lung function and reduction in severe exacerbations in adults and adolescents with moderate-to-severe asthma (GlobeNewswire)
03.09.20	Sanofi, GSK Begin Phase 1/2 Clinical Trial For Adjuvanted COVID-19 Vaccine Candidate - Quick Facts (RTTNews)
03.09.20	Sanofi and GSK initiate Phase 1/2 clinical trial of COVID-19 adjuvanted recombinant protein-based vaccine candidate (GlobeNewswire)
02.09.20	ATNX To Face FDA In Feb, ICPT Trims Workforce, JNCE Jumps On GILD Deal, SNY's Kevzara Flops Again (RTTNews)
01.09.20	Sanofi Says Kevzara Trial Failed To Meet Endpoints In COVID-19 Patients Outside U.S. (RTTNews)
01.09.20	Sanofi provides update on Kevzara® (sarilumab) Phase 3 trial in severe and critically ill COVID-19 patients outside the U.S. (GlobeNewswire)
28.08.20	Sanofi To Commence Tender Offer To Acquire Principia Biopharma (RTTNews)
28.08.20	Sanofi to commence tender offer for acquisition of Principia Biopharma Inc. (GlobeNewswire)
18.08.20	NVAX Begins Vaccine Trial In S.Africa, PSTX Slapped With Clinical Hold, UTHR To Face FDA In Apr. (RTTNews)
17.08.20	Sanofi Agrees To Buy Principia Biopharma In $3.68 Bln Deal - Quick Facts (RTTNews)
17.08.20	Sanofi to acquire Principia Biopharma (GlobeNewswire)
12.08.20	U.S. Reaches Deal With Moderna For 100 Million Doses Of COVID-19 Vaccine (RTTNews)
11.08.20	Perrigo To Acquire Three Eastern European OTC Self-Care Brands From Sanofi - Quick Facts (RTTNews)
03.08.20	Sanofi, GSK In Talks To Supply EU With Up To 300 Mln COVID-19 Vaccine Doses (RTTNews)
31.07.20	Sanofi and GSK in advanced discussions with European Union to supply up to 300 million doses of COVID-19 vaccine (GlobeNewswire)
31.07.20	Sanofi, GSK: COVID-19 Vaccine Candidate Selected By U.S. Government's Operation Warp Speed (RTTNews)
31.07.20	Sanofi and GSK selected for Operation Warp Speed to supply United States government with 100 million doses of COVID-19 vaccine (GlobeNewswire)
30.07.20	Nirsevimab reduced respiratory syncytial virus infections requiring medical care in healthy premature infants in Phase 2b trial (GlobeNewswire)
30.07.20	Nirsevimab reduced respiratory syncytial virus infections requiring medical care in healthy premature infants in Phase 2b trial (GlobeNewswire)
29.07.20	Online availability of Sanofi’s half-year financial report for 2020 (GlobeNewswire)
29.07.20	Sanofi, GSK In Deal With UK Government To Supply Up To 60 Mln Doses Of COVID-19 Vaccine (RTTNews)
29.07.20	Sanofi and GSK agree with the UK government to supply up to 60 million doses of COVID-19 vaccine (GlobeNewswire)
17.07.20	Sanofi Reportedly Considers Acquisitions Of U.S. Biotechnology Companies (RTTNews)
09.07.20	Kymera Partners With Sanofi To Advance Novel Protein Degrader Therapies (RTTNews)
08.07.20	Kiadis Licenses Previously Undisclosed Pre-clinical K-NK-cell Programs To Sanofi - Quick Facts (RTTNews)
06.07.20	Availability of the Pre-quarterly Results Communication (GlobeNewswire)
03.07.20	Sanofi, Regeneron Stop Kevzara COVID-19 Trial In U.S. After Failing To Meet Key Goals (RTTNews)
03.07.20	IMMU Continues Ascent, IDXG On Fire, REGN's Kevzara Disappoints In COVID-19 Trial, BLFS On Watch (RTTNews)
02.07.20	Sanofi and Regeneron provide update on Kevzara® (sarilumab) Phase 3 U.S. trial in COVID-19 patients (GlobeNewswire)
26.06.20	Sanofi Plans To Cut 1,700 Jobs In Europe (RTTNews)
24.06.20	Translate Bio (TBIO) Delivers 175% Gain In Little Less Than 3 Months (RTTNews)
24.06.20	INO Hits New High, APYX Expands Footprint, TBIO/SNY To Begin COVID-19 Vaccine Trial In Q4 (RTTNews)
23.06.20	Sanofi, Translate Bio Expand Collaboration To Develop MRNA Vaccines For Infectious Diseases (RTTNews)
23.06.20	Sanofi’s virtual R&D Day event to highlight capabilities, platforms, and expertise in disease pathways to deliver potentially transformative treatments to patients (GlobeNewswire)
23.06.20	Sanofi and Translate Bio expand collaboration to develop mRNA vaccines across all infectious disease areas (GlobeNewswire)
19.06.20	Sanofi announces positive long-term efficacy and safety data for fitusiran from interim analysis of Phase 2 extension study in people with hemophilia A and B, with or without inhibitors (GlobeNewswire)
19.06.20	Regeneron : China Okays Dupixent To Treat Moderate-to-Severe Atopic Dermatitis In Adults (RTTNews)
19.06.20	Dupixent® (dupilumab) approved in China for adults with moderate-to-severe atopic dermatitis (GlobeNewswire)
16.06.20	Sanofi: Avalglucosidase Phase 3 Trial Shows Clinically Meaningful Improvement (RTTNews)
16.06.20	Sanofi’s investigational enzyme replacement therapy shows clinically meaningful improvement in critical manifestations of late-onset Pompe disease (GlobeNewswire)
16.06.20	Sanofi To Create Production Site, Research Center In France Dedicated To Vaccines (RTTNews)
16.06.20	Sanofi invests to make France its world class center of excellence in vaccine research and production (GlobeNewswire)
15.06.20	Sanofi, Sobi Donate Up To 500 Mln Addl IUs Of Clotting Factor To WFH Humanitarian Aid Program (RTTNews)
11.06.20	Sanofi To Present Strategy For Dupixent In Type 2 Inflammatory Diseases (RTTNews)
11.06.20	Sanofi to present growth opportunities and development strategy for Dupixent® (dupilumab) in type 2 inflammatory diseases (GlobeNewswire)
09.06.20	Alphamab Oncology, Sanofi Collaborate On KN026 In HER2+ Breast Cancer (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Lonza Grp	534.60	0.68 %	K V
Sonova Hldg	305.40	0.26 %	K V
Alcon	77.72	0.13 %	K V
Novartis	92.01	0.09 %	K V
Roche Hldg G	251.50	0.04 %	K V
UBS Group	27.54	-0.79 %	K V
CieFinRichemont	121.30	-0.86 %	K V
ABB	49.03	-1.03 %	K V
Sika	225.00	-1.57 %	K V
Logitech Intl	70.40	-2.20 %	K V

mehr

12:26		Mittwochshandel in Frankfurt: TecDAX gibt am Mittag nach
12:26		XETRA-Handel: SDAX zeigt sich fester
12:26		Börse Zürich in Rot: SLI gibt nach
12:26		Angespannte Stimmung in Zürich: SPI präsentiert sich am Mittwochmittag schwächer
12:26		Schwacher Wochentag in Europa: So performt der Euro STOXX 50 mittags
12:26		Börse Zürich in Rot: So bewegt sich der SMI am Mittag
12:26		Gewinne in London: FTSE 100 am Mittag mit Kursplus
11:16		Novartis-Aktie etwas höher: EU-Zulassung für Kisqali - Funktion des Schweizer Länderpräsidenten gestrichen

12:26

Mittwochshandel in Frankfurt: TecDAX gibt am Mittag nach

12:26

XETRA-Handel: SDAX zeigt sich fester

12:26

Börse Zürich in Rot: SLI gibt nach

12:26

Angespannte Stimmung in Zürich: SPI präsentiert sich am Mittwochmittag schwächer

12:26

Schwacher Wochentag in Europa: So performt der Euro STOXX 50 mittags

12:26

Börse Zürich in Rot: So bewegt sich der SMI am Mittag